Anti-tumor effect of pEgr-interferon-γ-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism

Chinese Medical Journal

Volumn 118, Issue 4, 2005, Pages 296-301

  Yang, Wei ^a   Li, Xiu Yi ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Endostatin; Gene radiotherapy; Interferon ; Lung neoplasm; Plasmid pEgr

Indexed keywords

ENDOSTATIN; GAMMA INTERFERON; PEGINTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; DRUG RESPONSE; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH RATE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LUNG CARCINOMA; MACROPHAGE; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENDOSTATINS; FEMALE; GENE THERAPY; IMMEDIATE-EARLY PROTEINS; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PLASMIDS; TRANSCRIPTION FACTORS; X-RAY THERAPY;

EID: 14644390320     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Weichselbaum RR, Kufe DW, Hellman S, et al. Radiation-induced tumour necrosis factor-α expression: clinical application of transcriptional and physical targeting of gene therapy. Lancet Oncol 2002;3:665-671.
2. Marples B, Greco O, Joiner MC, et al. Radiogenetic therapy: strategies to overcome tumor resistance. Curr Pharm Des 2003;9:2105-2112.
3. Weichselbaum RR, Kufe DW, Advani SJ, et al. Molecular targeting of gene therapy and radiotherapy. Acta Oncologica 2001;40:735-738.
4. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36:169-180.
5. O'Relly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-285.
6. Merritt RE, Yamada RE, Crystal RG, et al. Augmenting major histo-compatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy. J Thorac Cardiovasc Surg 2004;127:355,364.
7. Xiang J, Moyana T. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo. Cancer Gene Ther 1998;5:313-320.
8. Qin Z, Schwartzkopff J, Pradera F, et al. A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells. Cancer Res 2003;63:4095-4100.
9. Hayakawa Y, Takeda K, Yagita H, et al. IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. Blood 2002;100:1728-1733.
10. Van Der Velden AW, Thomas AA. The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 1999;31: 87-106.
11. Mizuguchi H, Xu Z, Ishii-Watabe A, et al. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 2000;1:376-382.
12. Sadanaga N, Nagoshi M, Lederer JA, et al. Local secretion of IFN-gamma induces an antitumor response: comparison between T cells plus IL-2 and IFN-gamma transfected tumor cells. J Immunother 1999;22:315-323.
13. Shi W, Teschendorf C, Muzyczka N, et al. Adenoassociated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo. Cancer Gene Ther 2002;9:513-521.
14. Tai KF, Chen PJ, Chen DS, et al. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors. J Gene Med 2003;5:386-398.
15. Shi W, Teschendorf C, Muzyczka N, et al. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiother Oncol 2003;66:1-9.